Drug overdose antidote Narcan goes over-the-counter
The FDA move came as a top Biden official called fentanyl overdose deaths ‘the single greatest challenge we face as a country.’ View original article Contributor: David Ovalle
The FDA move came as a top Biden official called fentanyl overdose deaths ‘the single greatest challenge we face as a country.’ View original article Contributor: David Ovalle
Alejandro Mayorkas told a Senate panel that the Biden administration was working with Mexico to “bring the fight to the cartels.” View original article Contributor: Nick Miroff
A Republican-led Idaho House bill would limit minors’ ability to travel for an abortion without parental consent, even in states where the procedure is legal. View original article Contributor: Timothy Bella
States will begin this week to sever an anticipated 15 million low-income Americans from Medicaid rolls that ballooned during the pandemic. View original article Contributor: Amy Goldstein
A new analysis examined deaths in Britain, where the company’s product was restricted in 2021 because of safety concerns. View original article Contributor: Apoorva Mandavilli
Narcan and other naloxone nasal sprays swiftly reverse an opioid overdose and are easy to use. View original article Contributor:
The F.D.A.’s decision to allow the overdose-reversing nasal spray to be sold over the counter means it will become much more widely available. View original article Contributor: Jan Hoffman
Narcan, a naloxone nasal spray, is now approved for over-the-counter sales and should be widely available by late summer. Experts say that these sprays can swiftly reverse an opioid overdose and are easy to use. Here’s how. View original article Contributor: The New York Times
The nasal spray reverses opioid overdoses and public health officials hope that making it more widely available could save lives and reduce the nation’s high rates of drug fatalities. View original article Contributor: Jan Hoffman
Phthalate alternative might harm brain development, health: Study ThePrint >View original article Contributor: